Back to top
more

TerrAscend Corp. (TSNDF)

(Delayed Data from OTC)

$0.81 USD

0.81
184,277

-0.05 (-5.81%)

Updated Sep 19, 2025 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (151 out of 245)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Is TerrAscend Corp. (TSNDF) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

TerrAscend Corp. (TSNDF) Shows Fast-paced Momentum But Is Still a Bargain Stock

by Zacks Equity Research

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, TerrAscend Corp. (TSNDF) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks Equity Research

TerrAscend Corp. (TSNDF) Just Flashed Golden Cross Signal: Do You Buy?

by Zacks Equity Research

Is it a good or bad thing when a stock experiences a golden cross technical event?

Zacks Equity Research

Fast-paced Momentum Stock TerrAscend Corp. (TSNDF) Is Still Trading at a Bargain

by Zacks Equity Research

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, TerrAscend Corp. (TSNDF) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks Equity Research

TerrAscend Corp. (TSNDF) Upgraded to Buy: Here's Why

by Zacks Equity Research

TerrAscend Corp. (TSNDF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

TerrAscend Corp. (TSNDF) Reports Q2 Loss, Beats Revenue Estimates

by Zacks Equity Research

TerrAscend Corp. (TSNDF) delivered earnings and revenue surprises of -50.00% and +0.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

TerrAscend Corp. (TSNDF) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

TerrAscend Corp. (TSNDF) delivered earnings and revenue surprises of -66.67% and 0.89%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

OraSure Technologies (OSUR) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

OraSure (OSUR) delivered earnings and revenue surprises of -20% and 0.73%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Zevia (ZVIA) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Zevia (ZVIA) delivered earnings and revenue surprises of 30.77% and 2.13%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

AdaptHealth Corp. (AHCO) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

AdaptHealth (AHCO) delivered earnings and revenue surprises of 10.53% and 0.45%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Green Thumb Industries Inc. (GTBIF) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Green Thumb Industries Inc. (GTBIF) delivered earnings and revenue surprises of 50% and 1.13%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Zevia (ZVIA) Reports Q1 Loss, Misses Revenue Estimates

by Zacks Equity Research

Zevia (ZVIA) delivered earnings and revenue surprises of 0% and 2.55%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

VAREX IMAGING (VREX) Q2 Earnings Lag Estimates

by Zacks Equity Research

VAREX IMAGING (VREX) delivered earnings and revenue surprises of -30.43% and 0.54%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

OraSure Technologies (OSUR) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

OraSure (OSUR) delivered earnings and revenue surprises of -16.67% and 32.89%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?